The FDA has published a Transparency Roadmap outlining its fiscal year 2026 milestones and fiscal year 2027 priorities across ...
Radiopharmaceutical therapy is exposing a broader challenge for clinical development: scientific innovation can advance only ...
In today's ACT Brief, we examine FDA input sought on early-phase ibogaine protocols, why mixed outsourcing models spread ...
A new request for information asks for comments on dose selection, safety monitoring, eligibility criteria, and oversight ...
Mixed outsourcing models have moved from exception to mainstream as sponsors look to allocate resources more deliberately, ...
In today's ACT Brief, we examine practical guidance for clinical operations teams beginning AI adoption, how hierarchical ...
Autonomous capability can expand via new tools, memory, prompts, and delegation despite unchanged models, necessitating ...
In this video interview, Claire Riches, VP of clinical solutions at Citeline, explains why combining analog trial performance ...
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated ...
In today's ACT Brief, we examine how data drives honest enrollment assumptions, why RWE infrastructure lags ambition, and the ...
In this Q&A, Sylviane de Viron of CluePoints and Abigail Dirks, MS, of Tufts CSDD discuss the findings of a collaborative ...
In this video interview, Claire Riches, VP of clinical solutions at Citeline, explains how AI is expanding endpoint selection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results